Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?

Treatment of relapsing-remitting multiple sclerosis

(2012) Aaron E. Miller et al.   CURRENT OPINION IN NEUROLOGY

Multiple sclerosis

(2012) Alyssa Nylander et al.   JOURNAL OF CLINICAL INVESTIGATION

Sex-related factors in multiple sclerosis susceptibility and progression

(2012) Rhonda R. Voskuhl et al.   Nature Reviews Neurology

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy

(2012) Marco Cosentino et al.   NEUROIMMUNOMODULATION

The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis

(2011) Bernd C. Kieseier   CNS DRUGS

Beta-interferon for multiple sclerosis

(2011) Richard A. Rudick et al.   EXPERIMENTAL CELL RESEARCH

Human FoxP3+ CD4+ regulatory T cells: their knowns and unknowns

(2011) Makoto Miyara et al.   IMMUNOLOGY AND CELL BIOLOGY

Dopamine Induces IL-6-Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

(2011) K. Nakano et al.   JOURNAL OF IMMUNOLOGY

 1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages

(2011) L. A. Grisanti et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

(2011) J.-M. Beaulieu et al.   PHARMACOLOGICAL REVIEWS

A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis

(2010) Samia J. Khoury et al.   ARCHIVES OF NEUROLOGY

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

(2010) Antonio Scalfari et al.   BRAIN

The changing demographic pattern of multiple sclerosis epidemiology

(2010) Nils Koch-Henriksen et al.   LANCET NEUROLOGY

Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis

(2010) Jacques De Keyser et al.   NEUROCHEMISTRY INTERNATIONAL

Disturbed regulatory T cell homeostasis in multiple sclerosis

(2010) Koen Venken et al.   TRENDS IN MOLECULAR MEDICINE

The immunoregulatory role of dopamine: An update

(2009) Chandrani Sarkar et al.   BRAIN BEHAVIOR AND IMMUNITY

Increasing CNS Noradrenaline Reduces EAE Severity

(2009) Maria Vittoria Simonini et al.   Journal of Neuroimmune Pharmacology

Role of dopamine in the physiology of T-cells and dendritic cells

(2009) Rodrigo Pacheco et al.   JOURNAL OF NEUROIMMUNOLOGY

The interplay between the immune and central nervous systems in neuronal injury

(2009) V. W. Yong et al.   NEUROLOGY

Multiple sclerosis immunology: The healthy immune system vs the MS immune system

(2009) L. H. Kasper et al.   NEUROLOGY

Alterations of the dopamine transporter in resting lymphocytes of patients with different psychotic disorders

(2009) Donatella Marazziti et al.   PSYCHIATRY RESEARCH

Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis

(2008) Kazuhisa Nakano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Therapy with interferon-β modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis

(2008) Mauro Zaffaroni et al.   EXPERIMENTAL NEUROLOGY

Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance

(2008) Jacques De Keyser et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The role of regulatory T cells in multiple sclerosis

(2008) Alla L Zozulya et al.   Nature clinical practice. Neurology

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

(2007) John S. Tzartos et al.   AMERICAN JOURNAL OF PATHOLOGY